Advanced MedTech Holdings

Advanced MedTech Holdings

The firm's founding year is not publicly disclosed. Advanced MedTech Holdings (AMTH) is wholly owned by Temasek Holdings, the Singapore state investment company, and is headquartered in Singapore. Its subsidiaries include Dornier MedTech, WIKKON, Northern Litho, and NextMed, with manufacturing through AMT Pte. Ltd. AMTH operates as a vertically integrated urology company, with focus on stone management (lithotripsy) and prostate health, as well as robotic surgery tools. The company's portfolio covers over 100 countries, with a leading global position in stone lithotripsy. AMTH's revenue and AUM are not publicly disclosed; the firm describes itself as "profitable, high-growth" with a strong R&D pipeline. The company employs over 1,000 employees globally. Additional offices are located in Marlborough, United States, and Tokyo, Japan. No recent operational events from the last 24 months have been publicly disclosed. AMTH's structural differentiator is its status as a wholly owned subsidiary of Temasek Holdings, the Singapore sovereign wealth fund, providing it with patient capital and a long-term strategic mandate. This ownership structure allows the firm to pursue a fully integrated model—from manufacturing to global distribution—within the specialized urology market.